吸入氧化的案例报告,用于输血相关的急性肺损伤
Satoshi Kometani1, Ryo Misawa1, Michihiko Kawai1
1Anesthesiology, Yamato Seiwa Hospital, Yamato, JPN.
Cureus
|August 9, 2023
概括
与输血相关的急性肺损伤 (TRALI),一种急性呼吸困扰综合征 (ARDS) 的形式,可以通过吸入的氧化 (iNO) 来管理. 本案例研究表明,iNO在TRALI患者中可能避免体外膜氧化 (ECMO).
科学领域:
- 关键护理医学 关键护理医学
- 呼吸系统医学 呼吸系统医学
- 心血管外科心血管外科
背景情况:
- 输血相关的急性肺损伤 (TRALI) 是急性呼吸应急综合征 (ARDS) 的一种严重形式,发生在输血后不久.
- 吸入的氧化 (iNO) 已知会导致选择性肺血管扩张,并在ARDS中暂时改善氧化,但没有显示出死亡益处.
- 心血管外科手术患者有急性呼吸道并发症的风险,包括TRALI.
更多相关视频
08:23Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
4.0K
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.9K
相关概念视频
01:29Acute Respiratory Failure-V
163
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
163
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
263
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
263
01:21Acute Respiratory Failure-II
272
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
272